SLC6A3 and neurodegenerative disease: Parkinson’s disease (PD) is a neurodegenerative disease characterized by the selective degeneration of dopaminergic neurons in the pars compacta of the substantia nigra (SN) and striatal terminals, with reduction of the dopamine transporters (DAT).